KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molina Healthcare (MOH) Current Deferred Revenue (2016 - 2025)

Molina Healthcare's Current Deferred Revenue history spans 16 years, with the latest figure at $73.0 million for Q3 2025.

  • For Q3 2025, Current Deferred Revenue fell 79.95% year-over-year to $73.0 million; the TTM value through Sep 2025 reached $73.0 million, down 79.95%, while the annual FY2024 figure was $51.0 million, 87.8% down from the prior year.
  • Current Deferred Revenue for Q3 2025 was $73.0 million at Molina Healthcare, up from $57.0 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $691.0 million in Q3 2023 and bottomed at $1.0 million in Q3 2021.
  • The 5-year median for Current Deferred Revenue is $328.0 million (2024), against an average of $261.5 million.
  • The largest annual shift saw Current Deferred Revenue crashed 98.36% in 2021 before it surged 66200.0% in 2022.
  • A 5-year view of Current Deferred Revenue shows it stood at $370.0 million in 2021, then decreased by 2.97% to $359.0 million in 2022, then rose by 16.43% to $418.0 million in 2023, then tumbled by 87.8% to $51.0 million in 2024, then soared by 43.14% to $73.0 million in 2025.
  • Per Business Quant, the three most recent readings for MOH's Current Deferred Revenue are $73.0 million (Q3 2025), $57.0 million (Q2 2025), and $369.0 million (Q1 2025).